chlamydia: affect males

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents infection
Weight: 0.54
, organism
Weight: 0.33
Siblings syphilis
Weight: 0.35
, gonorrhea
Weight: 0.35
, lyme disease
Weight: 0.34
, genital herpes
Weight: 0.34

Related properties

Property Similarity
affect males 1.00
affect females 0.95
be active in males 0.87
be higher in females 0.84
be diagnosed in males 0.82
be such threat to females 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.39
Similarity weight: 1.00
Evidence: 0.80
¬ Remarkable(chlamydia, affect males)
Evidence: 0.76
¬ Remarkable(gonorrhea, affect males)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.76
Remarkable(gonorrhea, affect males)
Evidence: 0.60
¬ Plausible(gonorrhea, affect males)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.77
¬ Salient(chlamydia, affect males)

Similarity expansion

0.76
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.95
Evidence: 0.54
Typical(chlamydia, affect males)
Evidence: 0.13
¬ Typical(chlamydia, affect females)
0.69
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.95
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.35
¬ Plausible(chlamydia, affect females)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.62
¬ Salient(chlamydia, affect females)
0.66
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.95
Evidence: 0.80
Remarkable(chlamydia, affect males)
Evidence: 0.94
¬ Remarkable(chlamydia, affect females)
0.64
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.87
Evidence: 0.80
Remarkable(chlamydia, affect males)
Evidence: 0.70
¬ Remarkable(chlamydia, be active in males)
0.64
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.82
Evidence: 0.80
Remarkable(chlamydia, affect males)
Evidence: 0.47
¬ Remarkable(chlamydia, be diagnosed in males)
0.61
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.84
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.61
¬ Salient(chlamydia, be higher in females)
0.61
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.87
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.77
¬ Salient(chlamydia, be active in males)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.84
Evidence: 0.80
Remarkable(chlamydia, affect males)
Evidence: 0.79
¬ Remarkable(chlamydia, be higher in females)
0.59
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.82
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.68
¬ Salient(chlamydia, be diagnosed in males)
0.59
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.84
Evidence: 0.54
Typical(chlamydia, affect males)
Evidence: 0.39
¬ Typical(chlamydia, be higher in females)
0.58
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.84
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.47
¬ Plausible(chlamydia, be higher in females)
0.57
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.80
Remarkable(chlamydia, affect males)
Evidence: 0.81
¬ Remarkable(chlamydia, be such threat to females)
0.54
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.82
¬ Salient(chlamydia, be such threat to females)
0.54
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.87
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.67
¬ Plausible(chlamydia, be active in males)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.67
¬ Plausible(chlamydia, be diagnosed in males)
0.51
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.87
Evidence: 0.54
Typical(chlamydia, affect males)
Evidence: 0.67
¬ Typical(chlamydia, be active in males)
0.49
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.79
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.66
¬ Plausible(chlamydia, be such threat to females)
0.49
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.79
Evidence: 0.54
Typical(chlamydia, affect males)
Evidence: 0.60
¬ Typical(chlamydia, be such threat to females)
0.45
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.82
Evidence: 0.54
Typical(chlamydia, affect males)
Evidence: 0.77
¬ Typical(chlamydia, be diagnosed in males)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.77
Salient(chlamydia, affect males)
Evidence: 0.54
¬ Typical(chlamydia, affect males)
Evidence: 0.80
¬ Remarkable(chlamydia, affect males)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.60
Plausible(chlamydia, affect males)
Evidence: 0.54
¬ Typical(chlamydia, affect males)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.54
Similarity weight: 1.00
Evidence: 0.80
¬ Remarkable(chlamydia, affect males)
Evidence: 0.57
¬ Typical(gonorrhea, affect males)